Figure 2. Percentage of respondents who stated they would continue or bridge vitamin K antagonist therapy (VKA) or continue or disrupt (according to manufacturer’s guidelines or medical professional’s recommendations) direct oral anticoagulant (DOAC) therapy when undertaking extraction of one tooth, osteotomy of one tooth, extraction of 2-5 teeth, extraction of more than 5 teeth, or complex osteotomy.
